Skip to content

XIENCE V 1009543-15Recalls & reported problems

Abbott Vascular Inc. · XIENCE V Everolimus Eluting Coronary Stent System 4.00 mm x 15 mm / Rapid-Exchange · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648064418), received between Jan 10, 2018 and Jan 10, 2018 — classified as 1 death.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Angina1
  • Death1
  • Dyspnea1
  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • DeathJan 10, 2018Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2013 FOUR XIENCE STENTS WERE IMPLANTED IN THE PROXIMAL, MID, AND DISTAL RIGHT CORONARY ARTERY (RCA). ON (B)(6) 2016 THE PATIENT HAD STABLE ANGINA WITH DYSPNEA/SHORTNESS OF BREATH. DIAGNOSTIC CORONARY ANGIOGRAPHY WAS PERFORMED AND THE CONDITION RESOLVED. PERCUTANEOUS CORONARY INTERVENTION WAS PERFORMED FOR RESTENOSIS IN THE PROXIMAL AND DISTAL RCA STUDY LESIONS. THE PATIENT EXPIRED ON (B)(6) 2017 OF UNKNOWN CAUSE. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

    Patient problems: Angina; Death; Dyspnea; Stenosis

    MAUDE report 7180932 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page